Penn researchers announce latest results of investigational cellular therapy

The latest results of clinical trials of more than 125 patients testing a personalized cellular therapy known as CTL019 will be presented by University of Pennsylvania researchers at the 56th American Society of Hematology Annual Meeting and Exposition. Highlights of the new trial results will include a response rate of more than 90 percent among pediatric acute lymphoblastic leukemia patients, and results from the first lymphoma trials testing the approach. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *